BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 7495939)

  • 1. The relationship between the control of pH and healing and symptom relief in gastro-oesophageal reflux disease.
    Hunt RH
    Aliment Pharmacol Ther; 1995; 9 Suppl 1():3-7. PubMed ID: 7495939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of pH control in the management of GERD.
    Hunt RH
    Arch Intern Med; 1999 Apr; 159(7):649-57. PubMed ID: 10218743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. pH, healing rate, and symptom relief in patients with GERD.
    Huang JQ; Hunt RH
    Yale J Biol Med; 1999; 72(2-3):181-94. PubMed ID: 10780580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of gastric acid suppression in the treatment of gastro-oesophageal reflux disease.
    Bell NJ; Hunt RH
    Gut; 1992 Jan; 33(1):118-24. PubMed ID: 1346769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role and limitations of H2-receptor antagonists in the treatment of gastro-oesophageal reflux disease.
    Colin-Jones DG
    Aliment Pharmacol Ther; 1995; 9 Suppl 1():9-14. PubMed ID: 7495945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drugs, bugs, and esophageal pH profiles.
    Robinson M
    Yale J Biol Med; 1999; 72(2-3):169-72. PubMed ID: 10780578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological management of gastro-oesophageal reflux disease.
    Klinkenberg-Knol EC; Festen HP; Meuwissen SG
    Drugs; 1995 May; 49(5):695-710. PubMed ID: 7601011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review article: physiologic and clinical effects of proton pump inhibitors on non-acidic and acidic gastro-oesophageal reflux.
    Miner PB
    Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():25-32. PubMed ID: 16483267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of gastroesophageal reflux disease.
    Pettit M
    Pharm World Sci; 2005 Dec; 27(6):432-5. PubMed ID: 16341949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale for high-dose H2-receptor blockade in the treatment of gastro-oesophageal reflux disease.
    Castell DO
    Aliment Pharmacol Ther; 1991; 5 Suppl 1():59-67. PubMed ID: 1679673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acid suppression therapy: where do we go from here?
    Scarpignato C; Pelosini I; Di Mario F
    Dig Dis; 2006; 24(1-2):11-46. PubMed ID: 16699262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review article: current practice and future perspectives in the management of gastro-oesophageal reflux disease.
    Lambert R
    Aliment Pharmacol Ther; 1997 Aug; 11(4):651-62. PubMed ID: 9305472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
    Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
    Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review article: acid suppression in the management of gastro-oesophageal reflux disease--an appraisal of treatment options in primary care.
    Jones R; Bytzer P
    Aliment Pharmacol Ther; 2001 Jun; 15(6):765-72. PubMed ID: 11380314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term treatment of gastroesophageal reflux disease.
    van Pinxteren B; Numans ME; Lau J; de Wit NJ; Hungin AP; Bonis PA
    J Gen Intern Med; 2003 Sep; 18(9):755-63. PubMed ID: 12950485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis.
    Chiba N; De Gara CJ; Wilkinson JM; Hunt RH
    Gastroenterology; 1997 Jun; 112(6):1798-810. PubMed ID: 9178669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
    Hatlebakk JG; Berstad A
    Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Appropriate acid suppression in the treatment of acid-related conditions.
    Howden CW
    Pharmacol Ther; 1994; 63(1):123-34. PubMed ID: 7972343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    van Pinxteren B; Numans ME; Bonis PA; Lau J
    Cochrane Database Syst Rev; 2000; (2):CD002095. PubMed ID: 10796857
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.